Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 618.7 | 518.8 | 458.8 | 387.4 |
| Revenue growth | 19.3% | 13.1% | 18.4% | |
| Cost of goods sold | 185.8 | 155.2 | 162.0 | 144.9 |
| Gross profit | 432.8 | 363.6 | 296.7 | 242.5 |
| Gross margin | 70.0% | 70.1% | 64.7% | 62.6% |
| Sales and marketing | 139.3 | 115.8 | 110.4 | 98.2 |
| Research and development | 107.9 | 78.9 | 60.5 | 54.0 |
| General and administrative | 106.5 | 85.7 | 73.9 | 57.9 |
| EBITA | 79.9 | 78.7 | 47.1 | 28.9 |
| EBITA margin | 12.9% | 15.2% | 10.3% | 7.5% |
| Amortization of intangibles | 17.7 | 17.7 | 17.9 | 20.5 |
| EBIT | 62.2 | 61.0 | 29.2 | 8.4 |
| EBIT margin | 10.1% | 11.8% | 6.4% | 2.2% |
| Pre-tax income | 61.4 | 30.6 | -33.7 | -47.8 |
| Income taxes | 9.9 | 8.1 | -2.5 | -10.0 |
| Tax rate | 16.2% | 26.4% | 7.5% | 21.0% |
| Net income | 51.4 | 22.5 | -31.2 | -37.7 |
| Net margin | 8.3% | 4.3% | -6.8% | -9.7% |
| |
| Diluted EPS | $0.31 | $0.16 | ($0.23) | ($0.28) |
| Shares outstanding (diluted) | 165.8 | 142.5 | 135.2 | 135.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|